Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.835 USD | -7.22% | -18.14% | +63.41% |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
May. 24 | YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 | MT |
Sales 2024 * | 596M 82.33M | Sales 2025 * | 827M 114M | Capitalization | 1.14B 157M |
---|---|---|---|---|---|
Net income 2024 * | -297M -41.02M | Net income 2025 * | -122M -16.85M | EV / Sales 2024 * | 1.91 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-5.55
x | Employees | 773 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 18.57% |
1 day | -7.22% | ||
1 week | -18.14% | ||
1 month | +13.14% | ||
3 months | +94.64% | ||
6 months | +57.52% | ||
Current year | +63.41% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Chun Yuan Wu
DFI | Director of Finance/CFO | 46 | 20-12-30 |
Zenaida Mojares
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Viren Mehta
BRD | Director/Board Member | 74 | - |
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Ajit Shetty
CHM | Chairman | 77 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.835 | -7.22% | 70,601 |
24-05-30 | 0.9 | -3.23% | 325,241 |
24-05-29 | 0.93 | -7.92% | 46,987 |
24-05-28 | 1.01 | -0.98% | 179,363 |
Delayed Quote Nasdaq, May 31, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.41% | 157M | |
-2.36% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-18.13% | 7.32B |
- Stock Market
- Equities
- LSB Stock